ELIZABETH HARRIS: Open Payments
NPI 1366030850 · WOOSTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 117 payments from 13 companies in 2025. Trend: 2023 $773 · 2024 $384 · 2025 $1,538
Food & beverage: $1,454Education: $84
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 24 | $285 |
| Teva Pharmaceuticals USA, Inc. | 13 | $230 |
| Lundbeck LLC | 20 | $227 |
| Otsuka America Pharmaceutical, Inc. | 13 | $161 |
| ABBVIE INC. | 11 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $147 |
| E.R. Squibb & Sons, L.L.C. | 13 | $139 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $30 |
Products named: ARISTADA, ABILIFY MAINTENA, REXULTI, VRAYLAR, CAPLYTA, COBENFY, UZEDY, INGREZZA.
Industry payments across OH — which companies pay providers there.
